United States Nonalcoholic Fatty Liver Disease Market Report 2016

Publisher Name :
Date: 20-Sep-2016
No. of pages: 115
Inquire Before Buying

Notes:

Sales, means the sales volume of Nonalcoholic Fatty Liver Disease

Revenue, means the sales value of Nonalcoholic Fatty Liver Disease

This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Conatus Pharmaceuticals

- Daewoong Pharmaceutical

- Galmed International

- Kyorin Pharmaceutical

- Metabolic Solutions Development

- Novartis AG

- Phenex Pharmaceuticals

- Raptor Pharmaceuticals

- TCM Biotech International

- Tobira Therapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by Applications, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Nonalcoholic Fatty Liver Disease Market Report 2016

Table of Contents
United States Nonalcoholic Fatty Liver Disease Market Report 2016
1 Nonalcoholic Fatty Liver Disease Overview
1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Nonalcoholic Fatty Liver Disease
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)
1.4.1 United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
1.4.2 United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
2 United States Nonalcoholic Fatty Liver Disease Competition by Manufacturers
2.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nonalcoholic Fatty Liver Disease Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nonalcoholic Fatty Liver Disease Average Price by Manufactures (2015 and 2016)
2.4 Nonalcoholic Fatty Liver Disease Market Competitive Situation and Trends
2.4.1 Nonalcoholic Fatty Liver Disease Market Concentration Rate
2.4.2 Nonalcoholic Fatty Liver Disease Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Nonalcoholic Fatty Liver Disease Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
3.2 United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
3.3 United States Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
3.4 United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)
4 United States Nonalcoholic Fatty Liver Disease Sales (Volume) by Application (2011-2016)
4.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016)
4.2 United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Nonalcoholic Fatty Liver Disease Manufacturers Profiles/Analysis
5.1 Conatus Pharmaceuticals
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Daewoong Pharmaceutical
5.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Galmed International
5.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Kyorin Pharmaceutical
5.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Metabolic Solutions Development
5.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Novartis AG
5.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Phenex Pharmaceuticals
5.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Raptor Pharmaceuticals
5.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 TCM Biotech International
5.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Tobira Therapeutics
5.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Nonalcoholic Fatty Liver Disease Manufacturing Cost Analysis
6.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Nonalcoholic Fatty Liver Disease Market Forecast (2016-2021)
10.1 United States Nonalcoholic Fatty Liver Disease Sales, Revenue Forecast (2016-2021)
10.2 United States Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
10.3 United States Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)
10.4 Nonalcoholic Fatty Liver Disease Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Application of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Table United States Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers in 2015
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 3 Manufacturers
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 5 Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Sales by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Type in 2015
Table United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales by Application (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application in 2015
Table United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure United States Nonalcoholic Fatty Liver Disease Production and Growth Rate Forecast (2016-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Table United States Nonalcoholic Fatty Liver Disease Production Forecast by Type (2016-2021)
Table United States Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2016-2021)
  • Global Synovial Sarcoma Treatment Sales Market Report 2018
    Published: 17-May-2018        Price: US 4000 Onwards        Pages: 111
    This report studies the global Synovial Sarcoma Treatment market status and forecast, categorizes the global Synovial Sarcoma Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). In 2017, the global Synovial Sarcoma Treatment market size was xx million US$ and it is expected to reach ......
  • United States Veterinary Disinfectant Market Report 2018
    Published: 17-May-2018        Price: US 3800 Onwards        Pages: 97
    In this report, the United States Veterinary Disinfectant market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • United States Fibrin Market Report 2018
    Published: 17-May-2018        Price: US 3800 Onwards        Pages: 106
    In this report, the United States Fibrin market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Fibrin in......
  • Global Naloxone Sales Market Report 2018
    Published: 17-May-2018        Price: US 4000 Onwards        Pages: 107
    In this report, the global Naloxone market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Naloxone for these regions, from 2013 to 2025 (forecast), covering - United States - China - Europe - Japan - Southeast......
  • United States Human Placental Protein Market Report 2018
    Published: 17-May-2018        Price: US 3800 Onwards        Pages: 95
    In this report, the United States Human Placental Protein market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth ......
  • Global Blood Plasma Market Professional Survey Report 2018
    Published: 17-May-2018        Price: US 3500 Onwards        Pages: 119
    This report studies the global Blood Plasma market status and forecast, categorizes the global Blood Plasma market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Blood Plasma market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of ......
  • 2018-2025 Basal Cell Nevus Syndrome Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 17-May-2018        Price: US 3600 Onwards        Pages: 122
    Summary This report studies the Basal Cell Nevus Syndrome Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Basal Cell Nevus Syndrome Drug market by product type and application/end industries. The global Basal Cell Nevus Syndrome Drug market is valued at XX million USD in 2017 and is expected to reach X......
  • 2018-2025 Alpha N-Acetylglucosaminidase Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 17-May-2018        Price: US 3600 Onwards        Pages: 121
    Summary This report studies the Alpha N-Acetylglucosaminidase market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Alpha N-Acetylglucosaminidase market by product type and application/end industries. The global Alpha N-Acetylglucosaminidase market is valued at XX million USD in 2017 and is expected to reach XX m......
  • 2018-2025 Poly Polymerase 2 Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
    Published: 17-May-2018        Price: US 3600 Onwards        Pages: 125
    Summary This report studies the Poly Polymerase 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Poly Polymerase 2 market by product type and application/end industries. The global Poly Polymerase 2 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs